Evidence map›Paper›PMID 29158434›Full record

ArticleInfection and immunity2018

High Levels of Cyclic Di-GMP in Klebsiella pneumoniae Attenuate Virulence in the Lung.

David A Rosen, Joy Twentyman, David A Hunstad

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

  1. bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. A novelVirulence · 2025
    Article
  7. FromMicroorganisms · 2021
    Review
  8. Prophylaxis and Treatment againstInternational journal of molecular sciences · 2021
    Review
  9. Identification of hypervirulent Klebsiella pneumoniae isolates using the string test in combination with Galleria mellonella infectivity.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2020
    Article
  10. Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2020
    Review
  11. Article
  12. The Role of Nucleic Acid Sensing in Controlling Microbial and Autoimmune Disorders.International review of cell and molecular biology · 2019
    Review
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

David A RosenDivision of Pediatric Infectious Diseases, Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA rosend@wustl.edu.
Joy TwentymanDivision of Pediatric Infectious Diseases, Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA.
David A HunstadDivision of Pediatric Infectious Diseases, Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA.ORCID http://orcid.org/0000-0002-9848-0975
Washington University in St. Louis · US

Funding

pan-Genome of E.coli in the bladder and gut of women with recurrent UTIP50DK064540 · NIDDK · WASHINGTON UNIVERSITY · PI HULTGREN, SCOTT J. · 2002 to 2017
$17.9M
Training of the Pediatric Physician-ScientistT32HD043010 · NICHD · WASHINGTON UNIVERSITY · PI MARK E. LOWE · 2002 to 2026
$6.4M
Pediatric Infectious Diseases and Immunity Training ProgramT32AI106688 · NIAID · WASHINGTON UNIVERSITY · PI Megan Anne Cooper, DAVID HUNSTAD · 2014 to 2026
$1.9M
THE OUTER MEMBRANE AS A VIRULENCE PLATFORMR01DK080752 · NIDDK · WASHINGTON UNIVERSITY · PI HUNSTAD, DAVID · 2009 to 2013
$1.5M
VIRULENCE REGULATION AND PROTECTIVE IMMUNITY IN KLEBSIELLA PNEUMONIAK08AI127714 · NIAID · WASHINGTON UNIVERSITY · PI ROSEN, DAVID A. · 2017 to 2020
$703k
NIAID NIH HHS K08 AI127714NIAID NIH HHS T32 AI106688NICHD NIH HHS T32 HD043010NIDDK NIH HHS P50 DK064540NIDDK NIH HHS R01 DK080752
6 · The paper itself

Abstract

The bacterial second messenger bis-(3'-5')-cyclic dimeric GMP (c-di-GMP) has been shown to influence the expression of virulence factors in certain pathogenic bacteria, but little is known about its activity in the increasingly antibiotic-resistant pathogen

Indexed as

AnimalsCyclic GMPDisease Models, AnimalFemaleFimbriae, BacterialGene Knockdown TechniquesKlebsiella pneumoniaeLungMice, Inbred C57BLPneumonia, BacterialUp-RegulationVirulencebis(3',5')-cyclic diguanylic acidCyclic GMPcyclic di-GMPKlebsiella pneumoniaemurine modelpneumoniatype 1 pilitype 3 pilivirulence

Identifiers

PMID29158434
PMCPMC5778367
OpenAlexW2768247212

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.